Atypia of undetermined significance and nondiagnostic rates in the Bethesda system for reporting thyroid cytopathology are inversely related

American Journal of Clinical Pathology

Volumn 137, Issue 3, 2012, Pages 462-465

  VanderLaan, Paul A ^a   Renshaw, Andrew A ^b   Krane, Jeffrey F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BAPTIST HOSPITAL OF MIAMI   (United States)

Author keywords

Atypia of undetermined significance; Fine needle aspiration; Nondiagnostic; Quality assurance; Thyroid

Indexed keywords

ARTICLE; ASPIRATION BIOPSY; ATYPIA OF UNDETERMINED SIGNIFICANCE; CORRELATIONAL STUDY; CYTOPATHOLOGY; DISEASE CLASSIFICATION; MEDICAL INFORMATION SYSTEM; PRIORITY JOURNAL; THYROID CYTOPATHOLOGY BETHESDA REPORTING SYSTEM; ADENOCARCINOMA; CLASSIFICATION; COMPARATIVE STUDY; HUMAN; NEEDLE BIOPSY; PATHOLOGY; STANDARD; THYROID GLAND; THYROID TUMOR; THYROIDECTOMY;

ADENOCARCINOMA, FOLLICULAR; BIOPSY, FINE-NEEDLE; HUMANS; PATHOLOGY, SURGICAL; THYROID GLAND; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 84859340339     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCPI41QOQUSKDGP     Document Type: Article

References (16)

1. Ali SZ, Cibas ES. The Bethesda System for Reporting Thyroid Cytopathology . New York, NY: Springer; 2010.
2. Renshaw AA. Non-diagnostic rates for thyroid fine needle aspiration are negatively correlated with positive for malignancy rates. Acta Cytol. 2011;55:38-1.
3. Krane JF, VanderLaan PA, Faquin WC, et al.The atypia of undetermined significance/follicular lesion of undetermined significance: malignant ratio: a proposed performance measure for reporting in The Bethesda System for Thyroid Cytopathology [published online ahead of print September 14, 2011]. Cancer Cytopathol. In press.doi:.
4. Nayar R, Ivanovic M. The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer Cytopathol. 2009;117:195-202.
5. V600E mutation status. J Clin Endocrinol Metab. 2011;96:658-664.
6. Theoharis CG, Schofield KM, Hammers L, et al.The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution. Thyroid. 2009;19:1215-1223.
7. VanderLaan PA, Marqusee E, Krane JF. Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated FNA be the preferred initial approach? Am J Clin Pathol. 2011;135:770-775.
8. Marchevsky AM, Walts AE, Bose S, et al.Evidence-based valuation of the risks of malignancy predicted by thyroid fine-needle aspiration biopsies. Diagn Cytopathol. 2010;38:252-259.
9. Jo VY, Stelow EB, Dustin SM, et al.Malignancy risk for fine-needle aspiration of thyroid lesions according to The Bethesda System for Reporting Thyroid Cytopathology. Am J Clin Pathol. 2010;134:450-456.
10. Renshaw AA. Should "atypical follicular cells" in thyroid fine-needle aspirates be subclassified? Cancer Cytopathol. 2010;118:186-189.
11. Renshaw AA. Subclassification of atypical cells of undetermined significance in direct smears of fine-needle aspirations of the thyroid: distinct patterns and associated risk of malignancy. Cancer Cytopathol. 2011;119:322-327.
12. Abele JS, Levine RA. Diagnostic criteria and risk-adapted approach to indeterminate thyroid cytodiagnosis. Cancer Cytopathol. 2010;118:415-422.
13. Luu MH, Fischer AH, Pisharodi L, et al.Improved preoperative definitive diagnosis of papillary thyroid carcinoma in FNAs prepared with both ThinPrep and conventional smears compared with FNAs prepared with ThinPrep alone. Cancer Cytopathol. 2011;119:68-73.
14. Renshaw AA. Quantitative assessment of spray vs immersion fixation for thyroid fine-needle aspiration specimens. Am J Clin Pathol. 2010;133:796-798.
15. Renshaw AA. Does a repeated benign aspirate change the risk of malignancy after an initial atypical thyroid fine-needle aspiration? Am J Clin Pathol. 2010;134:788-792.
16. Faquin WC, Baloch ZW. Fine-needle aspiration of follicular patterned lesions of the thyroid: diagnosis, management, and follow-up according to National Cancer Institute (NCI) recommendations. Diagn Cytopathol. 2010;38:731-739.